Vulnerabilidades
Resumen — últimos 7 días
Vulnerabilidades nuevas2980▼ 83 respecto a la semana anterior
Críticas / altas1452▲ 101 respecto a la semana anterior
Nueva explotación activa (KEV)4▼ 5 respecto a la semana anterior
Sin puntuar (sin CVSS)353▼ 157 respecto a la semana anterior
2 resultados, ordenados por fecha de publicación (más recientes primero)
| CVE | Estado | Severidad | EPSS | Explotación activa | Tecnologías afectadas | Publicada ▼ | Modificada | Descripción |
|---|---|---|---|---|---|---|---|---|
| Modificada | Alta (8.5) | 0.50% | — | Smiths-medical Cadd-solis Medication Safety Software | 13/2/2017 | 17/6/2026 | An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints. | |
| Modificada | Crítica (9.9) | 1.5% | — | Smiths-medical Cadd-solis Medication Safety Software | 13/2/2017 | 17/6/2026 | An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change… |